Sex and Gender Effects in Pharmacology [E-Book] / edited by Stella E. Tsirka, Maricedes Acosta-Martinez.
Biological sex and gender have a tremendous impact on the efficacy and safety of pharmacological interventions in virtually every disease state. This book presents a comprehensive and up-to-date overview on how sex-specific information is guiding the diagnosis and treatment of diseases affecting men...
Saved in:
Full text |
|
Personal Name(s): | Acosta-Martinez, Maricedes, editor |
Tsirka, Stella E., editor | |
Edition: |
1st edition 2023. |
Imprint: |
Cham :
Springer,
2023
|
Physical Description: |
VIII, 288 pages 100 illustrations, 30 illustrations in color (online resource) |
Note: |
englisch |
ISBN: |
9783031426483 |
DOI: |
10.1007/978-3-031-42648-3 |
Series Title: |
/* Depending on the record driver, $field may either be an array with
"name" and "number" keys or a flat string containing only the series
name. We should account for both cases to maximize compatibility. */?>
Handbook of Experimental Pharmacology ;
282 |
Subject (LOC): |
- Part 1 Pharmacological Basic Principles
- The impact of sex and gender in medicine and pharmacology
- Sex differences in pharmacokinetics
- Clinical pharmacological considerations in transgender medicine
- Sex and gender differences in the pharmacology of the overactive urinary bladder
- Part 2 Pathologies of the Brain
- Sex differences in the evaluation and treatment of stroke
- Sex differences in pain and its treatment
- Therapeutics For Substance-Using Women: The Need To Elucidate Sex-Specific Targets For Better-Tailored Treatments
- Intersection of sex and depression: pathogenesis, presentation and treatments
- Biological and clinical implications of sex-specific differences in Alzheimer's disease
- Part 3 Diabetes, metabolic diseases & cardiovascular risk
- Gender Differences In Cardiovascular Health: Hormonal Effects on Cardiovscular Risk And Management. - Sex Differences in Glucose Homeostasis
- Sex-gender-based differences in metabolic diseases
- Hypothalamic pituitary gonadal axis disorders impacting fertility in both sexes and the potential of kisspeptin-based therapies to treat them.